BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38571874)

  • 1. Fluorodeoxyglucose (FDG) Uptake in the Remnant Adrenal Gland Mimicking Tumor Recurrence in a Patient With Adrenocortical Carcinoma After Treatment With Mitotane.
    Ayala Torres JD; Noreña Rengifo B
    Cureus; 2024 Mar; 16(3):e55486. PubMed ID: 38571874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prominent
    Al-Rashdan R; Aljaberi M; Mohamedkhair A; Al-Ibraheem A
    Asia Ocean J Nucl Med Biol; 2023; 11(2):181-184. PubMed ID: 37324222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicitve Value of FDG Uptake in the Remaining Adrenal Gland Following Adrenalectomy for Adrenocortical Cancer.
    Loewe R; Rogowski-Lehmann N; Pfluger T; Reincke M; Hahner S; Bluemel C; Fassnacht M; Beuschlein F
    Horm Metab Res; 2021 Jan; 53(1):24-31. PubMed ID: 33086388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High (18)F-FDG uptake by the remaining adrenal gland four months after surgery and initiation of mitotane treatment in two patients with adrenocortical carcinoma.
    Mpanaka I; Lyra VD; Kaltsas G; Chatziioannou SN
    Hell J Nucl Med; 2011; 14(2):168-72. PubMed ID: 21761022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET/CT image findings of a dog with adrenocortical carcinoma.
    Lee D; Yun T; Koo Y; Chae Y; Chang D; Yang MP; Kang BT; Kim H
    BMC Vet Res; 2022 Jan; 18(1):15. PubMed ID: 34980137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenocortical tumours? Preliminary results in 13 consecutive patients.
    Tenenbaum F; Groussin L; Foehrenbach H; Tissier F; Gouya H; Bertherat J; Dousset B; Legmann P; Richard B; Bertagna X
    Eur J Endocrinol; 2004 Jun; 150(6):789-92. PubMed ID: 15191348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma.
    Deandreis D; Leboulleux S; Caramella C; Schlumberger M; Baudin E
    Horm Cancer; 2011 Dec; 2(6):354-62. PubMed ID: 22076881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorodesoxyglucose uptake in the remaining adrenal glands during the follow-up of patients with adrenocortical carcinoma: do not consider it as malignancy.
    Leboulleux S; Deandreis D; Escourrou C; Al Ghuzlan A; Bidault F; Aupérin A; Travagli JP; Lumbroso J; Schlumberger M; Baudin E
    Eur J Endocrinol; 2011 Jan; 164(1):89-94. PubMed ID: 20921280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Association of Clinical Endocrinology Disease State Clinical Review on the Evaluation and Management of Adrenocortical Carcinoma in an Adult: a Practical Approach.
    Kiseljak-Vassiliades K; Bancos I; Hamrahian A; Habra M; Vaidya A; Levine AC; Else T
    Endocr Pract; 2020 Nov; 26(11):1366-1383. PubMed ID: 33875173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma.
    Ardito A; Massaglia C; Pelosi E; Zaggia B; Basile V; Brambilla R; Vigna-Taglianti F; Duregon E; Arena V; Perotti P; Penna D; Terzolo M
    Eur J Endocrinol; 2015 Dec; 173(6):749-56. PubMed ID: 26346137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET for the identification of adrenocortical carcinomas among indeterminate adrenal tumors at computed tomography scanning.
    Nunes ML; Rault A; Teynie J; Valli N; Guyot M; Gaye D; Belleannee G; Tabarin A
    World J Surg; 2010 Jul; 34(7):1506-10. PubMed ID: 20396886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
    Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
    Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic value of 18F-FDG PET/CT in comparison with morphological imaging in primary adrenal gland malignancies - a multicenter experience.
    Cistaro A; Niccoli Asabella A; Coppolino P; Quartuccio N; Altini C; Cucinotta M; Alongi P; Balma M; Sanfilippo S; Buschiazzo A; Piccardo A; Fanelli M; Sambuceti G; Bomanji J; Baldari S; Bisi G; Fanti S; Rubini G
    Hell J Nucl Med; 2015; 18(2):97-102. PubMed ID: 26187207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography.
    Werner RA; Kroiss M; Nakajo M; Mügge DO; Hahner S; Fassnacht M; Schirbel A; Bluemel C; Higuchi T; Papp L; Zsótér N; Buck AK; Bundschuh RA; Lapa C
    Endocrine; 2016 Sep; 53(3):791-800. PubMed ID: 27138903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG-PET/CT Evaluation of Indeterminate Adrenal Masses in Noncancer Patients.
    He X; Caoili EM; Avram AM; Miller BS; Else T
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1448-1459. PubMed ID: 33524123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI.
    Yun M; Kim W; Alnafisi N; Lacorte L; Jang S; Alavi A
    J Nucl Med; 2001 Dec; 42(12):1795-9. PubMed ID: 11752075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Imaging in the Management of Adrenocortical Cancer: A Systematic Review.
    Wong KK; Miller BS; Viglianti BL; Dwamena BA; Gauger PG; Cook GJ; Colletti PM; Rubello D; Gross MD
    Clin Nucl Med; 2016 Aug; 41(8):e368-82. PubMed ID: 26825212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoro-2-Deoxyglucose-Positron Emission Tomography/Computed Tomography in the Diagnosis and Management of Adrenocortical Carcinoma: A 10-Year Experience from a Tertiary Care Institute.
    Krishnaraju VS; Kumar R; Subramanian K; Mittal BR; Singh H; Chatterjee D; Walia R
    Indian J Nucl Med; 2022; 37(3):227-235. PubMed ID: 36686301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Interesting Case of Hepatic Adrenocortical Carcinoma.
    Permana H; Darmawan G; Ritonga E; Kusumawati M; Miftahurachman M; Soetedjo NN
    Acta Med Indones; 2018 Jul; 50(3):257-259. PubMed ID: 30333277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.